Form 4 for SONM DNA X, Inc.
Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-21 · accession 0000899243-22-023558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-22 | 2022-06-21 | SONM | TIRVA ROBERT L. | Pres, CFO, COO | S - Sale | $0.54 | -10.4K | 324.5K | -3% | -$5,595 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-21 | S | D | 10,361 | $0.54 | 324,524 | D | — | — | (F1) Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. (F2) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.54 to $0.5414, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F3) Includes 32,124 RSUs. Each RSU represents the right to receive one share of the Issuer's common stock. |